Latest News & Updates

Breaking News

  • 1 day ago

  • Simantini Singh Deo

Sanofi Acquires Vigil Neuroscience To Expand Neurology Portfolio With Potential Alzheimer’s Disease Treatment
Breaking News
AstraZeneca Acquires EsoBiotec For Up To $1B To Accelerate In Vivo Cell Therapy Innovation

Simantini Singh Deo

Aligos Therapeutics Appoints Laura Kavanaugh As VP, Head Of Legal To Support Clinical And Corporate Growth

Simantini Singh Deo

Arbor Biotechnologies Strengthens Leadership With The Appointment Of Don Haut, Ph.D., As Chief Business Officer

Simantini Singh Deo

Regeneron to Acquire 23andMe’s Key Assets for $256 Million, Expanding Genetic Data Capabilities

Simantini Singh Deo

Other trending news you may like to read

Dianthus Therapeutics Expands Board Of Directors With The Appointment Of Simon Read, Ph.D.

Dianthus appoints biotech veteran Dr. Simon Read to Board as Lonnie Moulder steps down.

Simantini Singh Deo

Article

FDA Grants Approval For Roche’s Susvimo In Diabetic Retinopathy Patients

Roche’s Susvimo receives FDA approval as the first continuous delivery treatment for diabetic retinopathy.

Simantini Singh Deo

Article

PacBio Expands Distribution In China, Partnering With Haorui Gene To Access New Clinical Lab Networks

PacBio partners with Haorui Gene to expand HiFi long-read sequencing for clinical genomics in China.

Simantini Singh Deo

Article

Astellas And Pfizer Present 5 And 8 Year Prostate Cancer Data Supporting XTANDI’s Survival Benefit

Astellas and Pfizer's XTANDI shows 5-year survival benefit with 30% reduced death risk in prostate cancer trials.

Vaibhavi M.

Article